Skip to main content

Month: May 2025

DLH Reports Fiscal 2025 Second Quarter Results

Solid Cash Flow and Debt Reduction Strengthen Financial Outlook as Bid Activity Accelerates ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2025. Second Quarter HighlightsSecond quarter revenue was $89.2 million in fiscal 2025 versus $101.0 million in fiscal 2024, reflecting small business conversions partially offset by contributions from contract awards. Earnings were $0.9 million, or $0.06 per diluted share, for the second quarter of fiscal 2025 versus $1.8 million, or $0.12 per diluted share, for the second quarter of fiscal...

Continue reading

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025   — Streamlining operations and focusing on delivering potential value generating program milestones, with workforce reduction of approximately 20% and cost reductions expected to extend cash runway into 2027    — Second development candidate expected to be announced in 2025   — Ended first quarter 2025 with $139.0 million in cash, cash equivalents and marketable securities     CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) — Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today reported financial results...

Continue reading

Mercado Libre builds on 2024 momentum with strong Q1 2025 results, reporting $5.9 billion revenue and $494 million net income

Montevideo, Uruguay. May 7, 2025, May 07, 2025 (GLOBE NEWSWIRE) —Unique buyers in commerce reached almost 67 million in the first quarter, with new buyers sustaining the highest level of growth since early 2021, and fintech monthly active users crossed 64 million in the first quarter, growing 31% YoY. Commerce value prop strengthens as brand preference reaches all-time highs in key markets and Fintech is seeing rising engagement. Argentina was the highlight of the quarter, capturing strong growth in GMV, TPV, credit and AUM given the strength of our competitive position and brand amid macro stabilization. Montevideo, Uruguay. May 7, 2025 — Mercado Libre (NASDAQ: MELI), the leading e-commerce and fintech platform in Latin America, kicked off the year with strong momentum, reporting solid results for the first quarter...

Continue reading

GXO Reports First Quarter 2025 Results

Increased first quarter revenue 21% year over year, to $3 billion, with organic revenue growth of 3% Grew sales pipeline to three-year high of $2.5 billion, excluding Wincanton Repurchased 2.8 million shares Reaffirmed full-year 2025 organic revenue growth and adjusted EBITDA guidanceGREENWICH, Conn. , May 07, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2025. Malcolm Wilson, chief executive officer of GXO, said, “GXO delivered a strong first quarter. We generated revenue of $3 billion, up 21% year over year, and delivered $163 million in adjusted EBITDA. “We signed $228 million of new business wins and our sales pipeline of $2.5 billion, excluding Wincanton, stands at its highest level in three years. We’ve finalized a landmark deal with the England’s National Health...

Continue reading

Okeanis Eco Tankers Corp. – Files Two Registration Statements on Form F-3

ATHENS, Greece, May 07, 2025 (GLOBE NEWSWIRE) — Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), announced today that it has filed with the U.S. Securities and Exchange Commission (the “SEC”) a shelf registration statement on Form F-3 on May 7, 2025. The shelf registration statement will enable the Company to more quickly and efficiently raise capital in the future. It provides for up to $500,000,000 in capital, which may be used for, among other things, potential acquisitions, strategic initiatives, reducing outstanding debt or other general corporate purposes. In addition, the Company also filed with the SEC a separate “resale” registration statement on Form F-3 relating to the resale of up to 18,102,286 common shares that are beneficially held by affiliates of the Company and that are otherwise currently...

Continue reading

The Herzfeld Caribbean Basin Fund, Inc. Announces Special Meeting of Stockholders to be Held on June 17, 2025

MIAMI BEACH, Fla., May 07, 2025 (GLOBE NEWSWIRE) — The Herzfeld Caribbean Basin Fund, Inc. (NASDAQ: CUBA) (the “Fund”) today announced that the Fund has filed preliminary proxy materials (“Proxy Materials”) with the U.S. Securities and Exchange Commission in connection with a special meeting of stockholders to be held on June 17, 2025, for its stockholders to consider and vote on proposals necessary to approve the Fund’s conversion from its current investment strategy and redirect the Fund to focus on a “CLO Equity Strategy”. With this change, the Fund’s primary investment objective will change to a total return strategy with a secondary objective of generating high current income for stockholders. In accordance with the change in investment objective, the Fund will focus on investing in equity and junior debt tranches of collateralized...

Continue reading

Viemed Healthcare Announces First Quarter 2025 Financial Results

LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD):Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024.Net income attributable to Viemed for the quarter ended March 31, 2025 totaled $2.6 million, or $0.06 per diluted share, an increase of 64% over net income attributable to Viemed of $1.6 million, or $0.04 per diluted...

Continue reading

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increaseProduct Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 million in the same period last year, representing a 786% increase Adjusted EBITDA in the first quarter of 2025 was $20.5 million compared to negative $38.4 million in 2023 Full year guidance increased to $600-$700 million in top line revenue and $200-280 million adjusted EBITDA, following acquisition of proposed biosimilar to Cimzia Alvotech will conduct a business update conference call and live webcast on Thursday May 8, 2025, at 8:00 am ET (12:00pm GMT).REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company...

Continue reading

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increaseProduct Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 million in the same period last year, representing a 786% increaseAdjusted EBITDA in the first quarter of 2025 was $20.5 million compared to negative $38.4 million in 2023Full year guidance increased to $600-$700 million in top line revenue and $200-280 million adjusted EBITDA, following acquisition of proposed biosimilar to CimziaAlvotech will conduct a business update conference call and live webcast on Thursday May 8, 2025, at 8:00 am ET (12:00pm GMT).REYKJAVIK, Iceland, May 7, 2025 – Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing...

Continue reading

Orchid Island Capital Announces May 2025 Monthly Dividend and April 30, 2025 RMBS Portfolio Characteristics

  ● May 2025 Monthly Dividend of $0.12 Per Share of Common Stock  ● RMBS Portfolio Characteristics as of April 30, 2025  ● Next Dividend Announcement Expected June 10, 2025Vero Beach, Fla., May 07, 2025 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of May 2025. The dividend of $0.12 per share will be paid June 27, 2025 to holders of record of the Company’s common stock on May 30, 2025, with an ex-dividend date of May 30, 2025. The Company plans on announcing its next common stock dividend on June 10, 2025. The Company intends to make regular monthly cash distributions to its holders of common stock. In order to qualify as a real estate investment trust (“REIT”), the Company must distribute...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.